Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

BusinesswireApr 10 07:00

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

BusinesswireApr 1 19:00

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

BusinesswireMar 20 19:00

Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting

BusinesswireMar 7 20:00

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

BusinesswireMar 4 20:00

Antibe Therapeutics Non-GAAP EPS of -C$0.08

Seeking AlphaFeb 14 21:06